Butalamine

CAS : 22131-35-7

Ref. 3D-FB19369

Informations sur le produit

• Nom: Butalamine
• Synonymes: 5-[[2-(Dibutylamino)ethyl]amino]-3-phenyl-1,2,4-oxadiazoleN,N-Dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)-1,2-ethanediamine3-Phenyl -5-(dibutylaminoethylamino)-1,2,4-oxadiazole, 1,2,4-Oxadiazole, 5-[[2-(dibutylamino)ethyl]amino]-3-phenyl-, 1,2-Ethanediamine N1,N1-dibutyl-N2-(3-phenyl-1,2,4-oxadiazol-5-yl)-, 1,2-Ethanediamine, N,N-dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)-, 1,2-Ethanediamine, N¹,N¹-dibutyl-N²-(3-phenyl-1,2,4-oxadiazol-5-yl)-, 22131-35-7, 3-Phenyl-5-(dibutylaminoethylamino)-1,2,4-oxadiazole, 5-[[2-(Dibutylamino)ethyl]amino]-3-phenyl-1,2,4-oxadiazole, N,N-dibutyl-N'-(3-phenyl-1,2,4-oxadiazol-5-yl)ethane-1,2-diamine, N¹,N¹-Dibutyl-N²-(3-phenyl-1,2,4-oxadiazol-5-yl)-1,2-ethanediamine

Description

Butalamine is a fatty acid ester that has been shown to exhibit a range of biological properties, including anti-inflammatory, anticancer, and anthelmintic activity. It has also been shown to be effective in the treatment of infectious diseases and autoimmune diseases. Butalamine exhibits its anti-inflammatory effects by inhibiting the production of prostaglandins (PGs) and leukotrienes (LTs). This inhibition leads to reduced inflammation, which helps with symptoms associated with microbial infection. Butalamine also has anticancer activity in animal models. The drug inhibits cancer cell proliferation by blocking the synthesis of DNA and RNA in the nucleus. Butalamine is most commonly used as an analog for butyl amine, which is used as a pharmaceutical dosage form.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 316.44 g/mol
• Formule: C₁₈H₂₈N₄O
• Degré de pureté: Min. 95%
• Couleur/Forme: Brown Powder
• InChI: InChI=1S/C18H28N4O/c1-3-5-13-22(14-6-4-2)15-12-19-18-20-17(21-23-18)16-10-8-7-9-11-16/h7-11H,3-6,12-15H2,1-2H3,(H,19,20,21)
• Code InChI: InChIKey=VYWQZAARVNRSTR-UHFFFAOYSA-N
• SMILES: CCCCN(CCCC)CCNc1nc(-c2ccccc2)no1